Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
JYNARQUE is a federal award for 262-Network Contract Office 22 (36C262) held by Otsuka America Pharmaceutical, Inc. Estimated value $285K ($285K obligated). Current period of performance ends Jun 30, 2024. Last award drew 1 bidder. Place of performance: PITTSBURGH PA.
Recompete timing
PublicCurrent PoP ended Jun 30, 2024 (782 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26223F0477?
36C26223F0477 (Jynarque) is a 262-Network Contract Office 22 (36C262) award with a potential value of $285K, currently held by Otsuka America Pharmaceutical, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C262-23-F-0477?
36C262-23-F-0477 is the dashed form of PIID 36C26223F0477 (Jynarque), held by Otsuka America Pharmaceutical, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26223F0477?
262-Network Contract Office 22 (36C262) awarded 36C26223F0477 to Otsuka America Pharmaceutical, Inc (potential $285K).
Who is the incumbent on 36C26223F0477?
Otsuka America Pharmaceutical, Inc is the incumbent. The current period of performance ends Jun 30, 2024.
When does Otsuka America Pharmaceutical, Inc’s 36C26223F0477 come up for recompete?
SCOUT tracks a period-of-performance end of Jun 30, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.